Flexible Spending Accounts will reimburse you for incurred expenses during your FSA plan year (period of coverage).
“Incurred” refers to expenses that happen after a service or product is provided – not when you are billed or pay for the service.You cannot be reimbursed in advance for any services.
Because FSA funds are available to you on the first day of your plan year, you must be able to receive full reimbursement for your contribution.
So, if you opted in for $1,200 a year for your FSA, you could use that amount on the first day (if you wanted to).
You can submit for FSA reimbursement in two ways:
1. Your FSA Administrator might provide you with an FSA Debit Card to use toward FSA eligible expenses.
You’ll be able to use the card at approved stores or pharmacies (we accept FSA Debit Cards and all major credit cards at FSAstore.com!)
By using the FSA debit card, your expenses are auto-adjudicated (electronically approved or disapproved) from the card and you may not need to submit additional receipts to your FSA Administrator.
Some FSA Administrators could still require a receipt to substantiate a claim. Check with your FSA Administrator about reimbursement procedures for your plan.The FSA Debit Card would not be charged if something is not considered FSA eligible under your plan.
2. You’ll have to typically submit a reimbursement claims form with:
- your personal details,
- product/service details(provider information)
- amount owed
- date of service provided.
FSAstore.com can provide you with an itemized receipt after you make your order to submit to your FSA Administrator for FSA reimbursement.
Gentamicin is used topically in the treatment of superficial infections of the skin caused by susceptible bacteria. However, substantial evidence of effectiveness is lacking and some experts question the use of topical antibiotics in general. Minor skin infections and wounds usually heal without treatment, and systemic anti-infective therapy is required for the treatment of serious or extensive skin infections. In addition, indiscriminate use of topical gentamicin may result in the emergence of organisms resistant to the drug and other aminoglycosides.
For systemic uses of gentamicin, see 8:12.02. For use of gentamicin in infections of the eye, see 52:04.04.
Dosage and Administration
Gentamicin sulfate is applied topically to the skin in the form of a cream or ointment containing 0.1% gentamicin. Because the ointment helps retain moisture, it has been used in the treatment of infections on dry, eczematous, or psoriatic skin. The cream is usually used for the treatment of wet, oozing primary infections and greasy secondary infections; the cream is also used if a water-washable preparation is desired.
A small amount of gentamicin cream or ointment should be applied gently to the cleansed affected area 3-4 times daily. The area may be covered with a sterile gauze dressing; infected stasis ulcers may be covered with gelatin packing. In the topical treatment of impetigo, crusts should be removed from the lesions to permit contact between the antibiotic and the infection. Care should be taken to avoid further contamination of the infected skin.
Gentamicin appears to have a low order of toxicity when applied to the skin; however, sensitization to the drug may occasionally result from topical application. In addition, commercially available gentamicin preparations contain other ingredients such as parabens which may also cause allergic contact dermatitis. Local irritation including erythema and pruritus occur rarely following topical application of gentamicin. Possible photosensitization has been reported in several patients treated with topical gentamicin, but the reaction could not be directly attributed to the drug.
Precautions and Contraindications
The use of gentamicin may result in overgrowth of nonsusceptible organisms including fungi. If superinfection occurs during gentamicin therapy, the drug should be discontinued and appropriate therapy instituted.
Serious adverse reactions including ototoxicity and nephrotoxicity have occurred in patients receiving systemic gentamicin therapy. (See Cautions in the Aminoglycosides General Statement 8:12.02.) The possibility of cumulative toxicity should be considered if gentamicin is applied topically to large skin lesions or large areas of denuded skin in combination with systemic aminoglycoside therapy.
Topical gentamicin is contraindicated in patients who are hypersensitive to the drug or any ingredients in the formulations. Patients who are hypersensitive to other topical antibiotics should be closely observed during treatment with gentamicin. If irritation or hypersensitivity occurs, the drug should be discontinued. Cross-allergenicity among the aminoglycosides has been demonstrated and the possibility that patients who become sensitized to topical gentamicin may also be sensitive to other topical and/or systemic aminoglycosides should be considered.
Gentamicin sulfate is not usually absorbed following topical application to intact skin; however, the drug is readily absorbed through denuded areas of skin or skin that has lost the keratin layer as in wounds, burns, or ulcers. Greater absorption may occur with topical application of gentamicin cream than with topical application of gentamicin ointment.